MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Genetics, Gene & Cell Therapy Companies
Lysogene
Organization & Developments: Lysogene
Parents
Lysogene
Children
2022: Lysogene, looking for saving grace after trial flop, suspends stock trading and seeks partners
2022: Lysogene's lead gene therapy flunks phase 2/3 trial almost a year after Sarepta walked out
Developing an innovative AAV gene therapy approach for the treatment of Fragile X syndrome, a genetic disease related to autism
Gene therapy company focused on the treatment of orphan diseases of the central nervous system (CNS).
Jumps
Finance & Acquisitions: Lysogene
Key People: Lysogene